HCA Healthcare (NYSE:HCA – Get Rating) had its target price lowered by Mizuho from $260.00 to $210.00 in a research note issued to investors on Friday, The Fly reports. The firm currently has a buy rating on the stock.
Other equities research analysts have also issued research reports about the company. TheStreet upgraded HCA Healthcare from a c+ rating to a b- rating in a research note on Monday, March 21st. Raymond James reduced their target price on HCA Healthcare from $275.00 to $245.00 and set an outperform rating on the stock in a report on Tuesday, April 26th. Sanford C. Bernstein raised HCA Healthcare from a market perform rating to an outperform rating and reduced their target price for the stock from $273.00 to $271.00 in a report on Thursday, May 26th. Truist Financial reduced their target price on HCA Healthcare from $310.00 to $250.00 and set a buy rating on the stock in a report on Monday, April 25th. Finally, Wells Fargo & Company reduced their target price on HCA Healthcare from $267.00 to $227.00 and set an equal weight rating on the stock in a report on Monday, April 25th. Five equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of Moderate Buy and an average target price of $255.41.
Shares of NYSE:HCA opened at $175.06 on Friday. The firm has a market capitalization of $51.73 billion, a PE ratio of 8.24, a P/E/G ratio of 1.17 and a beta of 1.61. The company has a debt-to-equity ratio of 87.46, a current ratio of 1.43 and a quick ratio of 1.24. The business has a 50-day moving average of $201.28 and a two-hundred day moving average of $234.51. HCA Healthcare has a 12 month low of $165.88 and a 12 month high of $279.02.
HCA Healthcare (NYSE:HCA – Get Rating) last announced its quarterly earnings results on Friday, April 22nd. The company reported $4.12 EPS for the quarter, missing the consensus estimate of $4.27 by ($0.15). The firm had revenue of $14.95 billion for the quarter, compared to analyst estimates of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The business’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.14 earnings per share. As a group, research analysts anticipate that HCA Healthcare will post 17.12 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Thursday, June 30th. Stockholders of record on Thursday, June 16th were given a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend was Wednesday, June 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.54%.
In other news, SVP Jennifer Berres sold 2,358 shares of HCA Healthcare stock in a transaction on Friday, May 13th. The stock was sold at an average price of $218.87, for a total transaction of $516,095.46. Following the transaction, the senior vice president now owns 11,392 shares in the company, valued at $2,493,367.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea B. Smith acquired 1,160 shares of HCA Healthcare stock in a transaction that occurred on Thursday, April 28th. The shares were purchased at an average cost of $213.63 per share, with a total value of $247,810.80. Following the transaction, the director now owns 2,239 shares of the company’s stock, valued at approximately $478,317.57. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 91,370 shares of company stock worth $19,373,375. 1.50% of the stock is owned by insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Commerce Bank boosted its position in HCA Healthcare by 6.1% during the fourth quarter. Commerce Bank now owns 6,859 shares of the company’s stock valued at $1,762,000 after purchasing an additional 392 shares during the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in shares of HCA Healthcare by 10.8% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 117,836 shares of the company’s stock worth $29,940,000 after buying an additional 11,453 shares during the last quarter. Wolf Group Capital Advisors lifted its position in shares of HCA Healthcare by 205.4% in the fourth quarter. Wolf Group Capital Advisors now owns 34,990 shares of the company’s stock worth $8,990,000 after buying an additional 23,533 shares during the last quarter. TD Asset Management Inc. lifted its position in shares of HCA Healthcare by 60.9% in the fourth quarter. TD Asset Management Inc. now owns 849,594 shares of the company’s stock worth $218,278,000 after buying an additional 321,524 shares during the last quarter. Finally, ProShare Advisors LLC lifted its position in shares of HCA Healthcare by 21.8% in the fourth quarter. ProShare Advisors LLC now owns 58,862 shares of the company’s stock worth $15,122,000 after buying an additional 10,528 shares during the last quarter. 67.87% of the stock is owned by hedge funds and other institutional investors.
About HCA Healthcare: (Get Rating)
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Recommended Stories:
Receive News & Ratings for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.
.